David Sherris Selected Research

David Sherris Research Topics

Disease

8	Neoplasms (Cancer) 10/2019 - 01/2007
2	Glioma (Gliomas) 10/2019 - 09/2013
2	Prostatic Neoplasms (Prostate Cancer) 06/2014 - 08/2011
2	Inflammation (Inflammations) 01/2011 - 06/2007
1	Wounds and Injuries (Trauma) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Breast Neoplasms (Breast Cancer) 09/2013
1	Brain Neoplasms (Brain Tumor) 09/2013
1	Glioblastoma (Glioblastoma Multiforme) 09/2013
1	Hypoxia (Hypoxemia) 11/2012
1	Keloid 11/2012
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2011
1	Disease Progression 01/2011
1	Pathologic Neovascularization 01/2011
1	Gliosis 09/2009
1	Proliferative Vitreoretinopathy 09/2009
1	Cicatrix (Scar) 09/2009
1	Retinal Detachment (Retinal Detachments) 09/2009
1	Bacterial Infections (Bacterial Infection) 06/2007
1	Rhinosinusitis 06/2007

Drug/Important Bio-Agent (IBA)

7	Mechanistic Target of Rapamycin Complex 1IBA 10/2019 - 11/2008
7	palomid 529IBA 06/2014 - 11/2008
6	Mechanistic Target of Rapamycin Complex 2IBA 10/2019 - 11/2008
4	Pharmaceutical PreparationsIBA 09/2013 - 11/2008
2	thiamine triphosphorate (TTP)IBA 10/2019 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 09/2013 - 11/2012
2	TOR Serine-Threonine KinasesIBA 11/2012 - 11/2008
2	Sirolimus (Rapamycin)FDA Link 11/2012 - 11/2008
1	Therapeutic UsesIBA 10/2019
1	Angiogenesis InhibitorsIBA 10/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 06/2014
1	SurvivinIBA 06/2014
1	DNA (Deoxyribonucleic Acid)IBA 06/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2013
1	Adenosine Triphosphate (ATP)IBA 09/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2012
1	WortmanninIBA 11/2012
1	Hormones (Hormone)IBA 08/2011
1	Cisplatin (Platino)FDA LinkGeneric 08/2011
1	Docetaxel (Taxotere)FDA Link 08/2011
1	CytokinesIBA 01/2011
1	ChemokinesIBA 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	MTOR InhibitorsIBA 01/2011
1	LectinsIBA 09/2009
1	Bromodeoxyuridine (BrdU)IBA 09/2009
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2007
1	Amphotericin B (Amphotericin)FDA LinkGeneric 06/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2007

Therapy/Procedure

4	Therapeutics 01/2018 - 01/2007
1	Drug Therapy (Chemotherapy) 10/2019
1	Radiotherapy 06/2014